Blood test study for predicting sepsis severity in ICU
Part of Infections clinical trials.
This study is testing a new blood test that measures IL-6 levels to help monitor patients with sepsis or septic shock in the ICU. It aims to see if the test can help doctors better understand how severe the infection is and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 22 years old or older.
- You have been diagnosed with sepsis or septic shock, meaning you have a serious infection causing organ problems or very low blood pressure.
- You are admitted or being admitted to the intensive care unit (ICU).
- A blood sample can be taken within 24 hours of your sepsis diagnosis.
- You are not currently in prison.
- You or your legal representative can give permission (informed consent) to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if a new blood test (Symphony IL-6) can help doctors quickly identify sepsis in patients coming to the emergency room. It may speed up diagnosis and treatment for serious infections.
This study compares two blood test methods to help predict sepsis (a severe infection) and patient outcomes in the intensive care unit. It may help doctors identify high-risk patients faster and more accurately.
This study is comparing two blood tests (Interleukin 6 and Procalcitonin) to find which is better at detecting sepsis (a serious infection) and predicting the risk of death in burn patients in the ICU. If you have moderate burns and are otherwise healthy, this trial could help improve care for burn victims.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study compares two blood test measurements (neutrophil/lymphocyte ratio and lactate/albumin ratio) to see which better predicts how severe an infection is in ICU patients with sepsis. It aims to find a simpler way to track inflammation.
Hear when a new Sepsis, Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.